NYSE: CNMDConmed Revenue
Conmed revenue was $1.32B for the trailing 12 months ending Mar 31, 2025, with 42.8% growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was $321.3M, down 7.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CNMD annual revenue was $1.3B, with 5% growth year-over-year.
CNMD past revenue growth
How has CNMD's revenue growth performed historically?
Company
4.32%
Industry
10.99%
Market
20.34%
CNMD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CNMD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CNMD's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
CNMD revenue history
Current Revenue
$1.3B
Current Earnings
$118.8M
Current Profit Margin
9%
CNMD's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance
Be the first to know when CNMD announces revenue.
CNMD Revenue History By Year
| CNMD Yearly Revenue | CNMD Revenue | CNMD Change | CNMD Revenue Growth |
|---|---|---|---|
| 2024-12-31 | $1.31B | $62.27M | +5.00% |
| 2023-12-31 | $1.24B | $199.27M | +19.06% |
| 2022-12-31 | $1.05B | $34.84M | +3.45% |
| 2021-12-31 | $1.01B | $148.18M | +17.18% |
| 2020-12-31 | $862.46M | -$92.64M | -9.70% |
| 2019-12-31 | $955.10M | $95.46M | +11.11% |
| 2018-12-31 | $859.63M | $63.24M | +7.94% |
| 2017-12-31 | $796.39M | $32.87M | +4.31% |
| 2016-12-31 | $763.52M | $44.35M | +6.17% |
| 2015-12-31 | $719.17M | -$20.89M | -2.82% |
| 2014-12-31 | $740.06M | -$22.65M | -2.97% |
| 2013-12-31 | $762.70M | -$4.44M | -0.58% |
| 2012-12-31 | $767.14M | $42.06M | +5.80% |
| 2011-12-31 | $725.08M | $11.35M | +1.59% |
| 2010-12-31 | $713.72M | $18.98M | +2.73% |
| 2009-12-31 | $694.74M | -$47.44M | -6.39% |
| 2008-12-31 | $742.18M | $47.90M | +6.90% |
| 2007-12-31 | $694.29M | $47.48M | +7.34% |
| 2006-12-31 | $646.81M | $29.51M | +4.78% |
| 2005-12-31 | $617.31M | $58.92M | +10.55% |
| 2004-12-31 | $558.39M | $61.26M | +12.32% |
| 2003-12-31 | $497.13M | $44.07M | +9.73% |
| 2002-12-31 | $453.06M | $24.34M | +5.68% |
| 2001-12-31 | $428.72M | $32.85M | +8.30% |
| 2000-12-31 | $395.87M | $19.65M | +5.22% |
| 1999-12-31 | $376.23M | $39.78M | +11.82% |
| 1998-12-31 | $336.44M | $198.17M | +143.32% |
| 1997-12-31 | $138.27M | $12.64M | +10.06% |
| 1996-12-31 | $125.63M | $26.07M | +26.19% |
| 1995-12-31 | $99.56M | $28.49M | +40.10% |
| 1994-12-31 | $71.06M | N/A | N/A |
Conmed Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.